Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 8 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4ID23
Term | Name | Level | Count |
---|---|---|---|
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 8 | 10 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 9 | 10 |
GO:0006396 | RNA processing | 6 | 10 |
GO:0006399 | tRNA metabolic process | 7 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008033 | tRNA processing | 8 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0008380 | RNA splicing | 7 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 10 |
GO:0034470 | ncRNA processing | 7 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0034660 | ncRNA metabolic process | 6 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000213 | tRNA-intron endonuclease activity | 6 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004518 | nuclease activity | 4 | 10 |
GO:0004519 | endonuclease activity | 5 | 10 |
GO:0004521 | RNA endonuclease activity | 5 | 10 |
GO:0004540 | RNA nuclease activity | 4 | 10 |
GO:0004549 | tRNA-specific ribonuclease activity | 5 | 10 |
GO:0016787 | hydrolase activity | 2 | 10 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 10 |
GO:0016892 | RNA endonuclease activity, producing 3'-phosphomonoesters | 6 | 10 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 6 | 10 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 10 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 10 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 10 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.541 |
CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.516 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.393 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.546 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.490 |
CLV_PCSK_PC1ET2_1 | 140 | 142 | PF00082 | 0.393 |
CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.528 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.489 |
CLV_PCSK_PC7_1 | 136 | 142 | PF00082 | 0.393 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.372 |
CLV_Separin_Metazoa | 70 | 74 | PF03568 | 0.422 |
DEG_APCC_DBOX_1 | 140 | 148 | PF00400 | 0.297 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.414 |
DEG_SCF_TRCP1_1 | 151 | 157 | PF00400 | 0.471 |
DOC_MAPK_gen_1 | 140 | 147 | PF00069 | 0.409 |
DOC_MAPK_gen_1 | 53 | 60 | PF00069 | 0.434 |
DOC_MAPK_MEF2A_6 | 140 | 147 | PF00069 | 0.393 |
DOC_PP4_FxxP_1 | 119 | 122 | PF00568 | 0.348 |
DOC_USP7_MATH_1 | 174 | 178 | PF00917 | 0.533 |
DOC_USP7_UBL2_3 | 176 | 180 | PF12436 | 0.573 |
LIG_14-3-3_CanoR_1 | 133 | 139 | PF00244 | 0.276 |
LIG_Actin_WH2_2 | 38 | 55 | PF00022 | 0.373 |
LIG_Actin_WH2_2 | 79 | 97 | PF00022 | 0.305 |
LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.401 |
LIG_FHA_1 | 118 | 124 | PF00498 | 0.433 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.472 |
LIG_FHA_2 | 110 | 116 | PF00498 | 0.405 |
LIG_FHA_2 | 144 | 150 | PF00498 | 0.310 |
LIG_FHA_2 | 157 | 163 | PF00498 | 0.323 |
LIG_HCF-1_HBM_1 | 89 | 92 | PF13415 | 0.341 |
LIG_LIR_Gen_1 | 67 | 77 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 67 | 72 | PF02991 | 0.497 |
LIG_SH2_CRK | 83 | 87 | PF00017 | 0.335 |
LIG_SH2_SRC | 107 | 110 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.468 |
LIG_SUMO_SIM_anti_2 | 43 | 50 | PF11976 | 0.394 |
LIG_SUMO_SIM_par_1 | 143 | 149 | PF11976 | 0.340 |
LIG_SUMO_SIM_par_1 | 155 | 162 | PF11976 | 0.439 |
LIG_TRAF2_1 | 146 | 149 | PF00917 | 0.299 |
LIG_TRAF2_1 | 41 | 44 | PF00917 | 0.371 |
LIG_TYR_ITIM | 105 | 110 | PF00017 | 0.300 |
MOD_CK1_1 | 152 | 158 | PF00069 | 0.497 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.437 |
MOD_CK2_1 | 109 | 115 | PF00069 | 0.407 |
MOD_CK2_1 | 143 | 149 | PF00069 | 0.445 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.373 |
MOD_Cter_Amidation | 138 | 141 | PF01082 | 0.341 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.540 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.477 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.413 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.506 |
MOD_GSK3_1 | 149 | 156 | PF00069 | 0.538 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.338 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.414 |
MOD_NEK2_1 | 143 | 148 | PF00069 | 0.394 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.515 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.430 |
MOD_NEK2_2 | 174 | 179 | PF00069 | 0.536 |
MOD_PIKK_1 | 47 | 53 | PF00454 | 0.329 |
MOD_PIKK_1 | 95 | 101 | PF00454 | 0.323 |
MOD_PKA_1 | 33 | 39 | PF00069 | 0.393 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.393 |
MOD_PKB_1 | 93 | 101 | PF00069 | 0.297 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.399 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.438 |
TRG_DiLeu_BaEn_1 | 43 | 48 | PF01217 | 0.380 |
TRG_DiLeu_BaEn_4 | 43 | 49 | PF01217 | 0.345 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.288 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.292 |
TRG_ER_diArg_1 | 171 | 173 | PF00400 | 0.571 |
TRG_ER_diArg_1 | 52 | 54 | PF00400 | 0.449 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.480 |
TRG_ER_diArg_1 | 92 | 95 | PF00400 | 0.162 |
TRG_NLS_MonoExtN_4 | 29 | 36 | PF00514 | 0.491 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4T2 | Leptomonas seymouri | 57% | 85% |
A0A0S4JEH5 | Bodo saltans | 27% | 100% |
A0A1X0P3G1 | Trypanosomatidae | 43% | 87% |
A0A3Q8IKM3 | Leishmania donovani | 100% | 100% |
A4HPP1 | Leishmania braziliensis | 84% | 100% |
D0A8H3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 72% |
E9ATF5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4Q142 | Leishmania major | 95% | 100% |